Victrex (LON:VCT – Get Free Report) had its target price reduced by Berenberg Bank from GBX 695 to GBX 600 in a report issued on Tuesday,London Stock Exchange reports. The brokerage currently has a “hold” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 1.18% from the stock’s current price.
VCT has been the topic of several other research reports. Jefferies Financial Group dropped their target price on Victrex from GBX 675 to GBX 595 and set a “hold” rating on the stock in a research report on Tuesday, May 12th. Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 target price on the stock. in a research report on Friday, May 15th. UBS Group reaffirmed a “sell” rating and set a GBX 575 target price on shares of Victrex in a research report on Monday, May 11th. Finally, JPMorgan Chase & Co. dropped their target price on Victrex from GBX 725 to GBX 625 and set a “buy” rating on the stock in a research report on Wednesday, March 18th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of GBX 662.86.
Read Our Latest Stock Report on VCT
Victrex Trading Down 0.9%
Victrex (LON:VCT – Get Free Report) last announced its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share (EPS) for the quarter. The business had revenue of £147.10 million for the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%. Equities analysts forecast that Victrex will post 73.1078905 EPS for the current fiscal year.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Articles
- Five stocks we like better than Victrex
- Walmart’s No. 2 Ranking Hides a Digital Transformation Story
- Campbell’s Soup Stock: Deep Value and a 7% Dividend Yield
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
